Denali Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | — | — | $39.9M |
| FY2017 | $20.9M | $486.7M | $218.4M |
| FY2018 | $115.1M | $662.0M | $77.1M |
| FY2019 | $158.3M | $553.2M | $79.4M |
| FY2020 | $453.7M | $1.60B | $507.1M |
| FY2021 | $441.9M | $1.40B | $293.5M |
| FY2022 | $417.8M | $1.46B | $218.0M |
| FY2023 | $123.0M | $1.15B | $127.1M |
| FY2024 | $144.5M | $1.37B | $175.0M |
| FY2025 | $131.1M | $1.14B | $205.3M |